President & CEO Litton, COO Lenington and CMO Moebius hold a virtual Research & Development Day entitled "Enhancing the HGF/MET System to Fight Neurodegenerative Diseases" on December 7 at 2 pm. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ATHA:
- Athira Pharma to hold a virtual research and development day
- Athira Pharma presents preclinical data on ATH-1105 in ALS
- Athira Pharma Highlights Therapeutic Potential of Fosgonimeton in Presentation of Additional Biomarker Data in Mild-to-Moderate Alzheimer’s Disease Patients from ACT-AD Phase 2 Study at CTAD Conference
- Athira Pharma: Data shows fosgonimeton treatment significantly improved NfL
- Athira Pharma to Present Additional Biomarker Data from ACT-AD Phase 2 Study of Fosgonimeton at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference